SI1771450T1 - Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora - Google Patents
Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze AuroraInfo
- Publication number
- SI1771450T1 SI1771450T1 SI200530184T SI200530184T SI1771450T1 SI 1771450 T1 SI1771450 T1 SI 1771450T1 SI 200530184 T SI200530184 T SI 200530184T SI 200530184 T SI200530184 T SI 200530184T SI 1771450 T1 SI1771450 T1 SI 1771450T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inhibition
- compounds
- methods
- aurora kinase
- mitotic progression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57165304P | 2004-05-14 | 2004-05-14 | |
| US61722104P | 2004-10-08 | 2004-10-08 | |
| PCT/US2005/016445 WO2005111039A2 (en) | 2004-05-14 | 2005-05-12 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
| EP05779921A EP1771450B9 (en) | 2004-05-14 | 2005-05-12 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1771450T1 true SI1771450T1 (sl) | 2008-06-30 |
Family
ID=39126531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200530184T SI1771450T1 (sl) | 2004-05-14 | 2005-05-12 | Spojine in postopki za inhibiranje mitotične progresije z inhibicijo kinaze Aurora |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1905773B1 (sl) |
| DK (1) | DK1905773T3 (sl) |
| PL (1) | PL1905773T3 (sl) |
| SI (1) | SI1771450T1 (sl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116514726A (zh) * | 2022-01-28 | 2023-08-01 | 四川大学 | 嘧啶类衍生物及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4547581A (en) | 1979-02-07 | 1985-10-15 | Hoffmann-La Roche Inc. | Pyrimido-2-benzazepines and intermediates in their preparation |
| US4318854A (en) | 1979-02-07 | 1982-03-09 | Hoffmann-La Roche Inc. | Intermediates in the production of 2-benzazepines |
| JP2001507349A (ja) * | 1996-12-23 | 2001-06-05 | セルテック セラピューティックス リミテッド | 縮合多環式２−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用 |
| GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
| US6653301B2 (en) * | 2000-12-21 | 2003-11-25 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
-
2005
- 2005-05-12 PL PL07024446T patent/PL1905773T3/pl unknown
- 2005-05-12 DK DK07024446.2T patent/DK1905773T3/da active
- 2005-05-12 EP EP07024446A patent/EP1905773B1/en active Active
- 2005-05-12 SI SI200530184T patent/SI1771450T1/sl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1905773T3 (da) | 2012-10-15 |
| EP1905773A3 (en) | 2008-04-09 |
| EP1905773B1 (en) | 2012-07-18 |
| PL1905773T3 (pl) | 2012-12-31 |
| EP1905773A2 (en) | 2008-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205102A1 (en) | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase | |
| ME00716B (me) | Jedinjenja i postupci za inhibiciju mitotičke progresije inhibiranjem aurora kinaze | |
| EP1957078A4 (en) | PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER BY INHIBITING AURORA KINASE | |
| HK1096972A1 (en) | Inhibition of syk kinase expression | |
| IL189933A0 (en) | Rna antagonist compounds for the inhibition of apo-b100 expression | |
| EP2121637A4 (en) | ANTHRANILAMIDE INHIBITORS OF AURORA KINASE | |
| HK1217699A1 (zh) | 抑制有絲分裂的化合物 | |
| IL190727A0 (en) | Method of inhibiting flt3 kinase | |
| GB2432165B (en) | Method of inhibiting hydrate formation | |
| ZA200704106B (en) | Inhibitors of c-fms kinase | |
| HK1144392A1 (en) | Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase | |
| GB0608823D0 (en) | Inhibitors of P13 kinase | |
| ZA200700826B (en) | Thienopyrimidines useful as Aurora kinase inhibitors | |
| ZA200809874B (en) | Method of inhibiting c kit kinase | |
| IL172375A0 (en) | Chinazoline derivatives as aurora kinase inhibitors | |
| IL182735A0 (en) | Inhibitors of c-fms kinase | |
| EP1906967A4 (en) | ABL Kinase Inhibition | |
| EP1778693A4 (en) | AS KINASEINHIBITORS USEFUL COMPOUNDS OF TRICYCLIC HETEROARYL | |
| SI1905773T1 (sl) | Spojine in postopki za inhibiranje mitotične progresije z inhibiranjem aurora kinaze | |
| PL1905773T3 (pl) | Związki i sposoby hamowania progresji mitotycznej poprzez hamowanie kinazy aurora | |
| EP1771203A4 (en) | INHIBITION OF NF-KB | |
| GB0410299D0 (en) | Inhibition of biofilm formation | |
| GB0621606D0 (en) | Inhibitors of p13 kinase | |
| GB0310268D0 (en) | Inhibition of biofilm formation | |
| GB0421680D0 (en) | A pharmacodynamic marker of p13 kinase inhibition |